These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25379273)

  • 21. Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions.
    Holtom PE; Needham PL; Bennett GW; Aspley S
    Br J Pharmacol; 2000 Nov; 131(5):990-6. PubMed ID: 11053221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does neurotensin mediate the effects of antipsychotic drugs?
    Kinkead B; Binder EB; Nemeroff CB
    Biol Psychiatry; 1999 Aug; 46(3):340-51. PubMed ID: 10435199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins.
    Griebel G
    Curr Pharm Des; 2015; 21(26):3807-12. PubMed ID: 26044977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder.
    Sharma RP; Janicak PG; Bissette G; Nemeroff CB
    Am J Psychiatry; 1997 Jul; 154(7):1019-21. PubMed ID: 9210757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotensin Induces Presynaptic Depression of D2 Dopamine Autoreceptor-Mediated Neurotransmission in Midbrain Dopaminergic Neurons.
    Piccart E; Courtney NA; Branch SY; Ford CP; Beckstead MJ
    J Neurosci; 2015 Aug; 35(31):11144-52. PubMed ID: 26245975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain neurotensin, psychostimulants, and stress--emphasis on neuroanatomical substrates.
    Geisler S; Bérod A; Zahm DS; Rostène W
    Peptides; 2006 Oct; 27(10):2364-84. PubMed ID: 16934369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
    Kinkead B; Dobner PR; Egnatashvili V; Murray T; Deitemeyer N; Nemeroff CB
    J Pharmacol Exp Ther; 2005 Oct; 315(1):256-64. PubMed ID: 15987829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.
    de Bartolomeis A; Latte G; Tomasetti C; Iasevoli F
    Mol Neurobiol; 2014 Feb; 49(1):484-511. PubMed ID: 23999870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
    Shilling PD; Richelson E; Feifel D
    Behav Brain Res; 2003 Jul; 143(1):7-14. PubMed ID: 12842291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of haloperidol and risperidone on neurotensin levels in brain regions and neurotensin efflux in the ventral striatum of the rat.
    Gruber SH; Nomikos GG; Mathé AA
    Neuropsychopharmacology; 2002 May; 26(5):595-604. PubMed ID: 11927184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotensin neural mRNA expression correlates with vocal communication and other highly-motivated social behaviors in male European starlings.
    Merullo DP; Cordes MA; Susan DeVries M; Stevenson SA; Riters LV
    Physiol Behav; 2015 Nov; 151():155-61. PubMed ID: 26192712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A neurotensin analog blocks cocaine-conditioned place preference and reinstatement.
    Boules M; Netz R; Fredrickson PA; Richelson E
    Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):236-9. PubMed ID: 26901162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs.
    Merchant KM; Dobie DJ; Dorsa DM
    Ann N Y Acad Sci; 1992; 668():54-69. PubMed ID: 1361120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotensin analogs indications for use as potential antipsychotic compounds.
    McMahon BM; Boules M; Warrington L; Richelson E
    Life Sci; 2002 Jan; 70(10):1101-19. PubMed ID: 11848295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics.
    Merchant KM; Dorsa DM
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3447-51. PubMed ID: 8097317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain.
    Kinkead B; Shahid S; Owens MJ; Nemeroff CB
    J Pharmacol Exp Ther; 2000 Oct; 295(1):67-73. PubMed ID: 10991962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotensin speeds inhibition of dopamine neurons through temporal modulation of GABA
    Tschumi CW; Beckstead MJ
    Neuropharmacology; 2018 Mar; 131():414-423. PubMed ID: 29307543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered neurotensin mrna expression in mice lacking the dopamine transporter.
    Roubert C; Spielewoy C; Soubrié P; Hamon M; Giros B; Betancur C
    Neuroscience; 2004; 123(2):537-46. PubMed ID: 14698760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DA2/NT receptor balance in the mesostriatal and mesolimbocortical systems after chronic treatment with typical and atypical neuroleptic drugs.
    Giardino L; Calzà L; Piazza PV; Zanni M; Amato G
    Brain Res; 1990 Nov; 532(1-2):140-5. PubMed ID: 1980851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.